Menu
Recruiting NCT07753291

The Effects of the Yi Jin Jing on the Muscles and Bones of Adults

No phase Interventional The Condition of Adults' Muscles and Bones

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Yijinjing.
Who it may be relevant to
Registry conditions: The Condition of Adults' Muscles and Bones. Basic parameters: 18 years — 90 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

Observation of the effects of Yi Jin Jing on the muscles and bones of adults

Interventions

  • Behavioral Yijinjing
    Yijinjing

Primary outcome measures

  • Appendicular Skeletal Muscle Index [Time frame: Day 180 ± 10 days]
Secondary outcome measures (5)
  • Handgrip strength [Time frame: Day 180 ± 10 days]
  • Nutrition intake form（MNA） [Time frame: Day 180 ± 10 days]
  • Fried [Time frame: Day 180 ± 10 days]
  • FRAIL [Time frame: Day 180 ± 10 days]
  • SPPB [Time frame: Day 180 ± 10 days]

Eligibility criteria

Inclusion criteria

1\) Age 18-90 years inclusive; 2) Generally healthy, no acute or chronic diseases affecting major organ functions; 3) No cognitive impairment, able to understand and comply with study procedures; 4) Willing and able to provide written informed consent; 5) No pregnancy or lactation (for females); 6) No recent (within 3 months) major surgery, hospitalization, or significant weight change (>5% body weight).

\-

Exclusion criteria

  • Presence of acute or unstable chronic diseases (e.g., uncontrolled hypertension, diabetes, heart failure, or malignancy);
  • Severe cognitive impairment, psychiatric disorders, or inability to follow study instructions;
  • Recent (≤3 months) major surgery, trauma, or hospitalization;
  • Pregnancy, lactation, or childbearing potential without reliable contraception;
  • Body mass index (BMI) <16 or >40 kg/m²;
  • Current use of medications affecting muscle or nutritional metabolism (e.g., corticosteroids, anabolic steroids);
  • Participation in another interventional trial within 30 days.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Prevention

Study locations

China · 1 center
  • No. 23, Ganju Road, Dongcheng District, Beijing — Beijing

Identifiers

NCT: NCT07753291 · 2025BL02-161-02

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗